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Research Article

Essential role of the Crk family-dosage in DiGeorge-like
anomaly and metabolic homeostasis
Akira Imamoto1 , Sewon Ki2, Leiming Li1, Kazunari Iwamoto3, Venkat Maruthamuthu4, John Devany5 , Ocean Lu1 ,
Tomomi Kanazawa3, Suxiang Zhang3, Takuji Yamada6, Akiyoshi Hirayama7, Shinji Fukuda7,8,9,10, Yutaka Suzuki11,
Mariko Okada2,3,12

CRK and CRKL (CRK-like) encode adapter proteins with similar
biochemical properties. Here, we show that a 50% reduction of
the family-combined dosage generates developmental defects,
including aspects of DiGeorge/del22q11 syndrome in mice. Like
the mouse homologs of two 22q11.21 genes CRKL and TBX1, Crk
and Tbx1 also genetically interact, thus suggesting that pathways
shared by the three genes participate in organogenesis affected
in the syndrome. We also show that Crk and Crkl are required
during mesoderm development, and Crk/Crkl deﬁciency results in
small cell size and abnormal mesenchyme behavior in primary
embryonic ﬁbroblasts. Our systems-wide analyses reveal impaired glycolysis, associated with low Hif1a protein levels as well
as reduced histone H3K27 acetylation in several key glycolysis
genes. Furthermore, Crk/Crkl deﬁciency sensitizes MEFs to 2deoxy-D-glucose, a competitive inhibitor of glycolysis, to induce
cell blebbing. Activated Rapgef1, a Crk/Crkl-downstream effector,
rescues several aspects of the cell phenotype, including proliferation, cell size, focal adhesions, and phosphorylation of p70
S6k1 and ribosomal protein S6. Our investigations demonstrate
that Crk/Crkl-shared pathways orchestrate metabolic homeostasis and cell behavior through widespread epigenetic controls.
DOI 10.26508/lsa.201900635 | Received 23 December 2019 | Revised 20
January 2020 | Accepted 21 January 2020 | Published online 10 February 2020

Introduction
CRK and CRKL (CRK-like), two paralogs of the CRK gene family, are
localized to 17p13.3 and 22q11.21 in the human genome, respectively.
CRK was ﬁrst identiﬁed as the avian oncogene v-CRK, followed by
the discovery of its cellular counterpart. CRKL was later identiﬁed in

human chromosome 22q11 based on its sequence similarities to
CRK (Feller, 2001; Birge et al, 2009). Evolutionary evidence suggests
that the two genes were generated by chromosomal duplication in
the common vertebrate ancestor (Shigeno-Nakazawa et al, 2016).
Despite their possible redundancy, CRKL has been implicated in
DiGeorge syndrome (DGS) as a dosage-sensitive gene that also
shows genetic interactions with TBX1, a key 22q11.21 gene (Guris
et al, 2006; Racedo et al, 2015), whereas ~90% of DGS patients have a
heterozygous 3-Mb microdeletion at 22q1.21, including these two
and several other genes (McDonald-McGinn et al, 2015).
Although haploinsufﬁciency of TBX1 has been strongly implicated in DGS, deﬁciency of mouse Crkl alone also affects normal
development of anterior/frontal structures, including facial features, great arteries, heart, thymus, and parathyroid, as well as
posterior structures, including genitourinary (GU) tissues, as collectively manifested as a condition that resembles DiGeorge anomaly
(Guris et al, 2001; Racedo et al, 2015; Haller et al, 2017; Lopez-Rivera et al,
2017). CRKL point mutations have also been identiﬁed among a large
cohort of patients with renal agenesis or hypodysplasia (Lopez-Rivera
et al, 2017). A distal region of the common deletion that includes CRKL
has been linked to GU defects among 22q11.2DS patients, and
haploinsufﬁciency of Crkl results in abnormal GU development in
mice (Haller et al, 2017; Lopez-Rivera et al, 2017). Although CRKL
coding mutations have not been linked to DGS without a 22q11
deletion, a recent study has identiﬁed non-coding mutations
predicted to affect CRKL expression in the hemizygous region of the
common 22q11 deletion with conotruncal defects (Zhao et al, 2020).
Therefore, a reduction of CRKL expression below 50% may contribute to expressivity and penetrance known to be highly variable
in DGS. On the other hand, CRK has not been established with a
ﬁrm link to congenital disorders to date, although it is localized to
the chromosomal region associated with Miller–Dieker syndrome
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(Bruno et al, 2010). Nevertheless, mouse phenotypes from genetic
ablations of either Crkl or Crk indicate that neither Crk nor Crkl
alone is sufﬁcient for normal development (Guris et al, 2001; Park et
al, 2006).
CRK and CRKL encode adapter proteins, consisting of SRC homology 2 and 3 domains (SH2 and SH3, respectively) without known
catalytic activities in an SH2-SH3-SH3 conﬁguration, whereas alternative splicing generates CRK “isoform b” (commonly noted as
“CRK-I” in contrast to the full length “isoform a” as “CRK-II”) that
does not include the C-terminal SH3 domain (Feller, 2001; Birge et
al, 2009). Most CRK/CRKL SH2-binding proteins have been identiﬁed
as transmembrane proteins (such as growth-factor/cytokine receptors and integrins) and their cytosolic components (Feller, 2001;
Birge et al, 2009). The task of inferring the speciﬁcs of their biological functions has been challenging due partly to co-expression
of CRK and CRKL. Several broadly expressed SH3-binding proteins
such as RAPGEF1 (C3G), DOCK1 (DOCK180), and ABL also co-exist in a
single cell in which they engage with multiple input signals to elicit
context-dependent coordinated responses.
To address the challenges noted above, we have used mouse
models in which either or both Crk and Crkl can be disrupted
conditionally. Developmental defects in the mouse models have
similarities to DGS, and normal development of the affected tissues
is sensitive to the combined gene dosage of the Crk and Crkl genes.
Furthermore, we report here a dosage-sensitive interaction between Crk and Tbx1, similar to the genetic interaction we previously
reported between the mouse homologs of two 22q11.21 genes, CRKL
and TBX1 (Guris et al, 2006). Therefore, investigation of the pathways
at the functional/genetic intersection of Crk and Crkl will be important for elucidating the mechanisms that underlie DiGeorge and
other related congenital syndromes. As we have found that the
mesoderm requires Crk and Crkl, we have chosen primary MEFs as a
mesoderm model. A series of unbiased systems-level analyses and
functional validations have revealed the shared dosage-sensitive
roles of Crk and Crkl in coordinating glucose metabolism and cell
size homeostasis by integrating regulatory pathways partly through
widespread epigenetic modiﬁcations.

ventricular septal defects (VSD) (Fig 1D), whereas one case accompanied an interrupted arch of aorta (IAA-B, Fig 1D), another case a right
aortic arch, one case a d-transposition of the great arteries (Fig 1D),
two cases with a double-outlet right ventricle (Fig 1D), two cases with a
cleft palate (Fig 1A), and two cases with cervical thymic lobes outside of
the thoracic cavity (Fig 1B).
Compound heterozygosity of Crk and Crkl is sufﬁcient to generate
an embryonic phenotype
Crk and Crkl were expressed in largely overlapping patterns at E10.5,
and the Crk-deﬁcient phenotype was similar to that of Crkl (Figs S2
and S3) (Guris et al, 2001). Therefore, we hypothesized that their
phenotypes may be attributed to a dosage-sensitive reduction in
their common functions. In addition to the Crk conditional allele,
we used a mouse strain that we previously generated with a
conditional mutation in the Crkl gene in which exon 2 is ﬂanked by
two loxP sites as Crklf2 allele (Haller et al, 2017; Lopez-Rivera et al,
2017). We ﬁrst conﬁrmed that the Crkl-deﬁcient embryonic phenotype generated by Crklf2/f2 and Meox2Cre/+ strains recapitulated
the Crkl null phenotype generated by deletion of Crkl exon 1, including arch artery and thymic defects (Fig S3). As predicted,
compound heterozygotes for Crkf and Crklf2 with Meox2Cre exhibited
an embryonic phenotype at E16.5, including severe edema and
enlarged blood vessels, a cleft palate, IAA-B, and right-sided aortic
arch accompanied by ventricular septal defect and small thymic
lobes (Fig 1E–H). IAA-B was reproducibly observed in Crk/Crkl compound heterozygous embryos (Fig 1I). This phenotype was similar in
multiple aspects to the phenotypes from homozygous deﬁciency of
either Crk or Crkl (Figs 1A–D and S3). Furthermore, compound heterozygotes between Crk and Tbx1 showed embryonic phenotypes at
E16.5 with greater penetrance and expressivity than that of either Crk
or Tbx1 single heterozygotes (Table S1). As these phenotypes shared a
constellation of DGS-like defects, our observations raise the hypothesis that DiGeorge and related syndrome may result from genetic
and environmental assaults on a part of the network sensitive to and
commonly dependent on the CRK family genes as well as TBX1.
The mesoderm requires at least two copies of the Crk
family-combined gene dosage

Results

To probe the functional signiﬁcance of the Crk family members, we
targeted the mouse Crk gene with a conditional approach by inserting
loxP sites upstream and downstream of Exon 1 (Crkf allele; Fig S1). A
germ-line Crk null allele (Crkd allele) was generated by Cre-mediated
recombination in the epiblast using a Meox2 Cre knock-in strain
(Tallquist & Soriano, 2000), followed by backcrosses with wild-type
C57BL/6 mice to segregate out Meox2Cre. In addition to the developmental defects previously reported in another Crk-deﬁcient mutant
(Park et al, 2006), we noted that homozygous Crkd/d embryos displayed
some aspects reminiscent of DiGeorge anomaly despite the fact that
CRK is not a 22q11 gene in humans (Figs 1A–D and 1A9–D9). Among three
Crkd/d embryos histologically examined, all three cases displayed

To further investigate shared roles that Crk and Crkl may play in
development, we generated Crk and Crkl deﬁciency in the mesoderm using Mesp1Cre (Saga et al, 1999). Some mice survived 50%
family-combined gene dosages reduced in the mesoderm lineages
without an overt phenotype in three genotypes: Crkf/f;Mesp1Cre/+,
Crklf2/f2;Mesp1Cre/+, and Crkf/+;Crklf2/+;Mesp1Cre/+. However, further
dosage reduction leaving only one copy of either Crkl or Crk in the
mesoderm (Crkf/f;Crklf2/+;Mesp1Cre/+, and Crkf/+;Crklf2/f2;Mesp1Cre/+,
respectively) resulted in abnormal embryos, associated with an
enlarged heart that failed to undergo looping when examined at
E9.5 (Fig 1J and K). In addition, they also had smaller numbers of
somites with a large proportion of the paraxial mesoderm left
unsegmented compared with that of control embryos. Although
vasculogenesis was initiated in the yolk sac mesoderm, the vascular
plexus failed to undergo remodeling in Crkf/+;Crkl f2/f2;Mesp1Cre/+
embryos recovered at E9.5 (Fig 1M). It is also noteworthy that
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Figure 1. Embryonic phenotypes from deﬁciencies of
Crk and Crkl in mice.
(A, B, C, D) Histologic sections from an E16.5 embryo
lacking Crk (Crkd/d) showed defects, including a cleft
palate (arrow in panel A), cervical/extra-thoracic
thymic lobes (red arrows in panel B, ts in panel C),
d-transposition of aorta and pulmonary trunk associated
with double-outlet right ventricle (C) and ventricular
septal defect (arrow in panel D). We also noted a
condition known as an interrupted aortic arch type B
(IAA-B) in panel (D) and other sections (not shown).
Asterisk in panel (A) indicates a dilated blood vessel.
Accompanied panels (A9, B9, C9, and D9) show sections
from a wild-type littermate corresponding to
sections (A, B, C, and D), respectively. Abbreviations
used in the panels are as follows: ns, nasal septum; ps,
palatal shelf; to, tongue; rcc, right common carotid
artery; lcc, left common carotid artery; ric, right internal
carotid artery; lic, left internal carotid artery; rec, right
external carotid artery; lec, left external carotid artery;
cv, cervical vertebra; tv1, thoracic vertebra 1; tv2, thoracic
vertebra 2; es, esophagus; t, trachea; ts, thymus; st, top of
the sternum (manubrium); co, ribs (costae); ao, aorta; pt,
pulmonary trunk; rv, right ventricle; and lv, left ventricle.
(E, F, G, H, I) Compound heterozygosity for Crk and Crkl
deﬁciency resulted in an embryonic phenotype at E16.5.
Timed mating was set up between Meox2cre/+ and Crkf/f;
Crklf2/f2 parents to drive cre-dependent recombination
in the epiblast. Compound heterozygotes (Crkf/+;
Crklf2/+;Meox2cre/+) showed severe edema and
subcutaneous hemorrhage at E16.5 (left, E), associated
with a cleft palate (F) and abnormal great arteries
and heart (G, H). Ink injection into the right ventricle
revealed an abnormal pattern of the great arteries such
as enlarged aorta without forming a left-sided arch
of aorta (ao, G) as well as a ventricular septal defect (G),
as ink ﬂowed into the left ventricles from the right
ventricle (dotted ellipses, G). When viewed from the
left side (panel H), pulmonary trunk abnormally
branched into the left common carotid artery via the
ductus arteriosus connected to the descending
aorta. A similar case of interrupted arch of aorta type B was found in another compound heterozygote in the same litter (I). Asterisk indicates an abnormal outﬂow tract
externally suspected to be a persistent truncus arteriosus. The compound heterozygote also exhibited a small cervical thymic lobe, which was removed before
examination of the great arteries. cp, cleft palate; pl, palate (closed); rcc, right common carotid artery; lcc, left common carotid artery; ao, aorta; rv, right ventricle; lv, left
ventricle; vsd, ventricular septal defect; da, descending aorta. (J, K, L, M) Early developmental defects were observed in E8.5 and E9.5 mouse embryos when combined Crk
and Crkl deﬁciency was induced in the mesoderm driven by Mesp1cre. The genotypes of the individual embryos shown (numbered from 1 through 11) are indicated below
the panels (K, L). Panels (J, K) show lateral views of embryos isolated at E9.5. Panel (L) shows dorsal views of two E8.5 embryos. Note that Crkf/f;Crklf2/+;Mesp1cre/+ and Crkf/
+
;Crklf2/f2;Mesp1cre/+ embryos were phenotypically similar (embryo 1 compared with embryos 2, 3, 7, and 8). Asterisks indicate enlarged hearts without proper looping and
chamber development. Arrowheads indicate the position of the posterior most somite visually identiﬁable, thereby indicating a delay in somitogenesis in Crkf/f;Crklf2/+;Mesp1cre/+
and Crkf/+;Crklf2/f2;Mesp1cre/+ embryos compared with cre-negative control embryos. ht, heart; al, allantois. Panel (M) shows embryos 6, 7, and 8 in yolk sac. Note a delay in
vascular remodeling in embryos 7 and 8, compared with the cre-negative control embryo (embryo 6).

embryos with only one copy of either Crkl or Crk (Crk f/f;Crklf2/+;
Mesp1Cre/+ or Crk f/+;Crkl f2/f2 ;Mesp1 Cre/+, respectively) showed
similar morphological defects. These results indicate that a developmental threshold requires at least 50% of the familycombined gene dosage during heart and somite development as
well as in the yolk sac mesoderm, through their shared functions.
We also identiﬁed Crk/Crkl double-deﬁcient embryos (Crk f/f;Crkl f2/f2;
Mesp1Cre/+) in the genetic crosses. They were much smaller than
either Crk f/f;Crkl f2/+;Mesp1Cre/+ or Crk f/+;Crkl f2/f2;Mesp1Cre/+ embryos, at E9.5 (Fig 1K). When isolated at E8.5, double-deﬁcient
embryos resembled the size and appearance of E7.5 embryos
(Fig 1L). Because normal onset of gastrulation is marked by the
emergence of Mesp1-positive mesoderm starting around E6.5 in
mice (Saga et al, 1999), these results indicate that Crk and Crkl are
absolutely required immediately after mesoderm induction.

Morphological and behavioral phenotypes in primary MEFs
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The results above suggest that mesodermal cells may provide a
useful system to investigate the shared functions of Crk and Crkl. To
this end, we isolated primary MEFs at E11.5 as a model for mesodermal cells. Using Rosa26-creERT2 in the background of the Crk f/f,
Crkl f2/f2, or Crk f/f;Crkl f2/f2 genotypes, deﬁciency of either or both
Crk and Crkl were induced by 4-hydroxytamoxifen (4OHT) over a
course of 72 h in Crk f/f;Crkl f2/f2;R26creERT2/+ MEFs (Fig 2A) (Ventura
et al, 2007). Crk-deﬁcient MEFs did not show abnormal motility when
plated in a clonal cell density (Fig S4). However, we noted that the
pH indicator phenol red in the culture medium did not turn yellow
when the cells were in a high density, associated with a morphology
change (Fig S4). These results demonstrated that Crk plays a role in
collective morphology, whereas the medium pH implicated an

vol 3 | no 2 | e201900635

3 of 18

Figure 2. Crk;Crkl deﬁciency induces multiple defects in MEFs.
(A) Crk and Crkl protein levels were determined in time course in immunoblots upon induction of Crk;Crkl deﬁciency. Crk f/f;Crkl f2/f2;R26creERT2/+ MEFs were induced for
Crk;Crkl deﬁciency by 4-hydroxytamoxifen (4OHT) treatment for 24 h, whereas a control group was treated with vehicle only (CTRL). Cell lysates were isolated from MEFs at
each time point indicated above each lane (0 h was the time right before 4OHT/vehicle addition). (B) Crk;Crkl double deﬁciency results in slow cell growth and altered
population morphology. Pictures were taken posttreatment day 2 for control and day 4 for Crk;Crkl deﬁciency group. Note that the cell density of Crk;Crkl-deﬁcient MEFs
on day 4 is similar to that of control group on day 2, and that population morphology is distinguishable between the 4OHT and control groups. (C) Time lapse images show
cell division from a single MEF (identiﬁed at 0:00 time) to two daughter cells in each group. In the control, cells migrated away from each other after division and were no
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impaired metabolic state. Upon induction of Crk/Crkl double deﬁciency, the cell morphology changed more drastically from a
typical ﬁbroblastic appearance to a compact/condensed appearance (Fig 2B). To explore the basis of this collective morphology, we
took time-lapse videos of dividing cells (Fig 2C). Normally, ﬁbroblastlike cells show repulsive movements upon cell–cell contacts,
known as contact inhibition of locomotion (CIL) (Roycroft & Mayor,
2016). Likewise, two daughter cells moved apart in the control
group upon cell division (Fig 2C). In contrast, the daughter cells in
the Crk/Crkl-deﬁcient group did not separate despite their
cell–cell contacts, thus exhibiting a failure related to CIL (Fig 2C).
The cell junctional marker β-catenin showed a greater accumulation to cell–cell junctions in the deﬁciency-induced group than
control, thus indicating elevated cell–cell adhesion in the
deﬁciency-induced MEFs (Fig 2D). A failure of post-mitotic CIL and
increased cell–cell contacts may explain the abnormal population
morphology in Fig 2B, thus demonstrating that Crk and Crkl play a
pivotal role in cell–cell haptic communication and behavior.
Essential roles of Crk and Crkl in spreading and cell size
We next determined the effects of Crk and Crkl deﬁciency, individually or combined, on cell spreading (Fig 2E). In our modiﬁed
spreading assay, we measured the surface area that each attached
cell occupied over time on gelatin-coated plates rather than
counting the number of spreading cells at each time point. We
found that compared with control MEFs, the process of spreading
was slower in deﬁciency of Crk or Crkl individually, and further
reduced in Crk/Crkl double deﬁciency as indicated by the slope of
spreading curves (Fig 2E).
During tissue culture, we became aware that the same number of
Crk/Crkl double-deﬁcient primary MEFs made visibly smaller pellets than that of control MEFs when harvested by dissociation and
centrifugation. The observation suggested the possibility that individual Crk/Crkl double-deﬁcient MEFs may be smaller than that
of control cells. Normally, cells undergo a controlled cell-size oscillation during cell cycle to maintain their sizes in a population
(Lloyd, 2013; Ginzberg et al, 2015). Therefore, we estimated the size of
primary MEFs in the G1 phase by light scatter measurements in FACS
analysis (Fig 2F). As anticipated, induction of Crk/Crkl double deﬁciency resulted in a size distribution shift smaller than that of
control primary MEFs, whereas Crk/Crkl double-deﬁcient MEFs
cells appeared to stay in the G1 phase for a longer time than the
control group (Fig S5). We also noted that the cell size was

smaller when kept conﬂuent for 4 d, compared with the groups
that were split on Day 2 to avoid overcrowding (all groups received daily media change). Therefore, these results demonstrate
that Crk and Crkl are essential for cell size homeostasis in G1,
whereas additional cell density–dependent mechanism may also
operate in parallel.
Transcriptome pathways dependent on Crk and Crkl
The complex phenotypes in development and in MEFs suggested
involvement of Crk and Crkl in multiple pathways. To gain insight
into the impaired network from a vantage view point, we conducted
a systems-level analysis by RNA-Seq in the primary MEFs in which
deﬁciency of each or both Crk and Crkl can be induced by 4OHT (Fig 3).
Differential expression (DE) was determined between deﬁciencyinduced and uninduced groups of primary MEFs in pair per single
embryo, using four independent embryos for each genotype with an
false discovery rate (FDR) cutoff of p.adj < 0.05 (Table S2 and Fig S6).
Fig 3A shows a heat map of the DE genes in protein synthesis (“EIF2
Signaling,” “Regulation of EIF4 and p70 S6K Signaling,” and “mTOR
Signaling”), growth factor signaling (“VEGF Signaling,” “IGF-1 Signaling,” “PTEN Signaling”), adhesion and cytoskeletal signaling
(“Integrin Signaling,” “Actin Cytoskeleton Signaling,” “FAK Signaling,”
“Paxillin Signaling,” “Signaling by Rho GTPases,” “RhoA Signaling,”
“Ephrin Receptor Signaling,” “Ephrin A Signaling,” “Gap Junction
Signaling”) (Supplemental Data 1).
Upon conducting “set operations,” we identiﬁed ~400 genes in
the common intersection among either Crk or Crkl single deﬁciency
and Crk/Crkl combined deﬁciency (Fig 3B, subset “red”; Supplemental Data 2). The DE genes in this subset are likely regulated by
the pathways that Crk and Crkl share in a “family dosage-sensitive”
manner. In addition to subset “red,” deﬁciency of either Crk or Crkl
also resulted in DE in subsets “orange” and “yellow,” respectively
(Fig 3B). While the DE genes identiﬁed in subsets “red,” “orange,”
and “yellow” were sensitive to a single deﬁciency of either Crk or
Crkl, subset “green” represents genes dependent on the shared
pathways that combined deﬁciency of both Crk and Crkl was
needed to disrupt (Fig 3B). In other words, either Crk or Crkl was
sufﬁcient to maintain normal expression of the genes in subset
“green” in primary MEFs. Therefore, subset “green” may represent
genes for which Crk and Crkl may be redundant. Although we
identiﬁed DE genes in Crk or Crkl deﬁciency not observed in Crk/
Crkl double-deﬁcient MEFs, numbers of these DE genes were too
small to draw interpretations in the current study.

longer visible together within the ﬁeld after 4 h. In contrast, Crk;Crkl-deﬁcient cells (4OHT-treated) stayed attached with one another, forming a two-cell island after
division. Movies are available as supplemental materials. (D) Cell–cell contacts were analyzed by immunostaining with anti-Ctnnb1 (β-catenin) antibody. Individual cells
are labeled by numbers. β-catenin localization highlights deﬁned zipper-like cell–cell contacts in Crk;Crkl-deﬁcient MEFs (4OHT-treated) compared with control MEFs.
Box and whisker plots show quantitative comparisons of β-catenin levels across cell–cell contacts shown in the images above the plots. Diamonds indicate intensity
values derived from tracing seven separate regions that encompass cell–cell contacts. Two plots demonstrate that Crk;Crkl-deﬁcient MEFs (4OHT-treated) had greater
accumulation of β-catenin at cell–cell contacts compared with control as shown in both average and maximum levels of the β-catenin staining (“average levels” and
“peak levels,” respectively). (E) The area of spreading was measured for individual cells after replating on a gelatin-coated surface (72 cells in each group). Note that
whereas MEFs lacking either Crk or Crkl showed smaller spread area at 60 and 90 min, Crk;Crkl double deﬁciency induced greater degrees of spreading defects over time
and did not show a signiﬁcant increase in the spread area between 60 and 90 min, thus suggesting that cell spreading reached a lower plateau compared with their
control (and that of either Crk or Crkl deﬁciency). (F) The cell size was estimated in dissociated Crk;Crkl-deﬁcient MEFs and their control in the G1 phase (4OHT and CTRL,
respectively). FSC-H values (forward scatter height) were analyzed and illustrated in a box-and-whisker plot. See Fig S5 for propidium iodide–binding proﬁles and gating
information for the FACS analysis. Each treatment group was subdivided into two subgroups with or without a split on day 2 posttreatment to adjust and maintain low cell
density until harvest on day 3 posttreatment.
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Figure 3. Crk and Crkl deﬁciencies affect numerous pathways.
(A) The heat map shows a list of the top 30 pathways based on comparison analysis of the Crk and/or Crkl single and double deﬁciency groups in Ingenuity Pathway
Analysis (QIAGEN; see Supplemental Data 1). RNA-Seq experiments were performed on RNA isolated from four independent primary MEF populations for each genotype as
described in the Materials and Methods section as well as in Table S2 and Supplemental Data 1. Differentially expressed genes (DE genes) were identiﬁed by
Benjamini–Hochberg adjusted P-values (p.adj) smaller than 0.05 using DESeq2. (B) Deﬁciencies for Crk and Crkl genes, separately or combined, resulted in overlapping
lists of DE genes, categorized into subsets a-g as shown in the Venn’s diagram. Subsets a, b, c, and d are referred to subsets “red,” “orange,” “yellow,” and “green” hereafter
(Supplemental Data 2). The number in each subset indicates the number of DE genes in the subset. The number below the gene symbol (Crk, Crkl, or Crk;Crkl) indicates the
total number of DE genes identiﬁed in the gene deﬁciency. The numbers in parentheses separated by colon show the numbers of genes up-regulated versus downregulated. Note that deﬁciency of either Crk or Crkl was sufﬁcient to disrupt normal expression of the genes in subset “red,” whereas the genes in subset “green” tolerated
single gene disruption of either Crk or Crkl. (C) The DE genes in subsets “red,” “orange,” “yellow,” and “green” were analyzed for their enrichment into pathways using KEGG
(Kyoto Encyclopedia of Genes and Genomes). The node circles and annotations are color-coded as appeared in panel (B). Nodes are labeled only for the KEGG modules
and pathways with Storey’s q-values smaller than 0.0005 (shown as FDRs), whereas node circles are shown for the pathways/modules with a q-value < 0.05. The diameter
of node circle is proportional to −log10(q-value).
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KEGG analysis
To further explore the dysregulated pathways, we categorized the
DE genes either “down-regulated” or “up-regulated” in each subset
(Supplemental Data 2). In subset “red,” we noted that down-regulated DE genes were enriched in several KEGG “pathways” and
“modules,” including glycolysis, aminoacyl-tRNA biosynthesis, HIF-1
signaling, regulation of actin cytoskeleton, and focal adhesion (Fig
3C, red circles). On the other hand, up-regulated DE genes in subset
“red” did not show signiﬁcant enrichment in a KEGG pathway or
module. Down-regulated DE genes in subset “orange” were associated with ribosome biogenesis and RNA transport, whereas the
up-regulated genes were mapped to the glucuronate pathway and
cytochrome P450-mediated drug metabolism (Fig 3C, orange circles).
Down-regulated genes in subset “yellow” were enriched in C5isoprenoid biosynthesis/mevalonate pathway, suggesting a speciﬁc role for Crkl in biosynthesis of cholesterol and other isoprenoids, whereas no enrichment was identiﬁed in the pathways or
modules for up-regulated genes (Fig 3C, yellow circles). Subset
“green” included many DE genes enriched in down-regulated
pathways, including oxidative phosphorylation, purine/pyrimidine
metabolism, spliceosome, ribosome, DNA repair and replication,
and cell cycle (Fig 3C, green circles). A few pathways, of which most
noticeable was NOD-like receptor signaling, appeared to be upregulated in subset “green,” thus implicating a redundancy between Crk and Crkl in regulating inﬂammasomes (Strowig et al, 2012;
Wen et al, 2013).

degraded under the ambient air oxygen level of 21% by the von
Hippel–Lindau tumor suppressor VHL and E3 ubiquitin ligase, the
degradation process is controlled under physiological O2 levels of
2–9% in tissues and embryonic environment (Simon & Keith, 2008;
Semenza, 2017). To investigate possible effects of Crk/Crkl deﬁciency on Hif1 pathways, we used CoCl2 to stabilize Hif1a proteins by
inhibiting VHL (Yuan et al, 2003). As anticipated, Hif1a levels increased in the nucleus in the presence of CoCl2 in both Crk/Crkl
deﬁciency-induced and uninduced MEFs (Fig 4D). However, the
CoCl2-induced increase was much smaller in Crk/Crkl deﬁciencyinduced MEFs than that of uninduced control MEFs (p.adj < 2 × 10−16).
Although the oxygen-rich environment under the standard tissue
culture condition masks Hif1a protein levels, a small difference was
also detectable between Crk/Crkl deﬁciency-induced MEFs than
that of uninduced control MEFs (p.adj < 2 × 10−16). These results
demonstrate that normal Hif1a protein production relies on Crk and
Crkl.
Crk/Crkl deﬁciency affects chromatin-level gene regulations

Several glycolysis enzymes have been identiﬁed as targets of the
transcription factor Hif1a (Fig 4A, labels in orange color) (Benita et
al, 2009). Although Hif alpha proteins (Hif1a and Hif2a) are rapidly

To explore the mechanism by which glycolysis enzyme expression
was down-regulated, we conducted genome-wide ChIP-Seq analysis with an active chromatin marker, acetylated histone H3 lysine27 along with RNA Polymerase II phospho-S5 CTD repeats (H3K27Ac
and Pol2, respectively). Association of H3K27Ac and Pol2 with
transcription start site (TSS)–proximal regions is a global feature of
actively transcribed genes, as H3K27Ac positively enhances the
search kinetics of transcription activators as well as the transition
of Pol2 from initiation to elongation by accelerating its promoter
escape (Stasevich et al, 2014).
H3K27Ac or Pol2 ChIP-Seq showed a positive correlation with
mRNA DE for the genes in subset “red” as Crk/Crkl-common and
Crk/Crk-sensitive targets (Fig 5A). In particular, the down-regulated
glycolysis genes in subset “red” were identiﬁed within the lower left
quadrant in the scatterplots (Fig 5A). Furthermore, the ChIP-Seq
reads for H3K27Ac and Pol2 were reduced globally in down-regulated
genes, compared with the up-regulated gene group (Fig 5B). Interestingly, the ChIP-Seq reads for H3K27Ac and Pol2 were not
increased for subset “red” up-regulated DE genes with their median
values in the negative range. Therefore, reduced mRNA levels of the
glycolysis genes were attributable largely to diminished transcription in Crk/Crkl-deﬁciency, whereas a separate mechanism
may drive increased steady mRNA levels for the up-regulated DE
genes in subset “red.”
In TSS-ﬂanking regions, we observed generally diminished ChIPSeq peaks for both H3K27Ac and Pol2 in Crk/Crkl-deﬁcient MEFs
compared with the control group (Fig 5C, KO versus CTRL in orange
and green lines, respectively). Consistent with the result shown in
Fig 5B, H3K27Ac and Pol2 signals were not increased for the
up-regulated genes in Crk/Crkl-deﬁcient MEFs. To quantify the
changes, boxplots were generated for the peak height of the ChIPSeq signals in the TSS ± 2 kb region (Figs 5D and S7). We noted
signiﬁcant differences in H3K27Ac signals between deﬁciency-induced
and uninduced MEFs (p.adj < 1 × 10−10 and p.adj = 8.97 × 10−04 in the
down-regulated and up-regulated gene categories, respectively). Pol2
ChIP-Seq signals were also highly different between deﬁciencyinduced and uninduced MEFs in the down-regulated gene
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Validating the role of Crk and Crkl in glycolysis
The transcriptome analysis above implicated shared family-critical
roles for Crk and Crkl in glycolysis and other metabolic pathways
(Fig 3). Using capillary electrophoresis time-of-ﬂight mass spectrometry (CE-TOFMS), we found that several metabolites in the
central glucose metabolism pathway were decreased (Fig 4A,
squares ﬁlled with shades of blue; Supplemental Data 3), consistent
with reduced transcript levels of several genes encoding glycolysis enzymes along the same pathway (Fig 4A, small circles
ﬁlled with shades of blue). Several metabolites and glycolytic
enzymes were affected not only in Crk/Crkl-double deﬁciency
but also in MEFs deﬁcient for either Crk or Crkl (Fig 4A, squares
and circles enclosed by magenta-colored line). Reduced mRNA
levels of several glycolysis enzymes initially identiﬁed by RNASeq were validated by quantitative real-time RT-PCR (Fig 4B).
Furthermore, chromatin immunoprecipitation (ChIP) followed by
quantitative/real-time PCR demonstrated that association of
RNA polymerase II phospho-S5 C-terminal domain (CTD) repeats
was reduced in Gapdh, Pgk1, and Ldha upon deﬁciency induction
(Fig 4C). As they belong to subset “red,” these glycolysis enzyme
genes are sensitive to a shared function of Crk and Crkl for their
transcription.
A role for Crk and Crkl in CoCl2-stabilized Hif1a protein pool
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Figure 4. Glucose metabolism is a common target of
Crk and Crkl deﬁciency.
(A) CE-TOF/MS metabolome analysis identiﬁed
differential levels of several metabolites in central
carbon metabolism in primary MEFs deﬁcient for
either Crk or Crkl, or for both Crk and Crkl. The
illustration is a compilation of metabolome and RNASeq results. Transporters, enzymes, and
metabolites affected in Crk;Crkl double deﬁciency
are highlighted by a color shade (shades of blue
indicate down-regulation; shades of red, upregulation). Nodes encircled by magenta lines are
affected not only in Crk;Crkl double deﬁciency but
also in single deﬁciencies of both Crk and Crkl.
Orange-colored labels indicate known targets of the
transcription factor Hif1a. (B) Quantitative RT-PCR
validated the results of RNA-Seq for several
glycolysis genes in primary MEFs deﬁcient for Crk and
Crkl. Levels of expression were expressed as a fold
change. The basal level without induction of Crk;
Crkl deﬁciency set at 1.0 as shown at the red dotted
line. Welch’s t test was performed on raw Ct values
between 4-hydroxytamoxyfen (4OHT)–treated and
CTRL groups (n = 3); P-values were 0.03462, 0.00061,
0.01735, 0.00027, 0.00834, and 0.00013 for Pfkl, Gapdh,
Pgk1, Pgam1, Eno1, and Ldha, respectively. (C)
Association of RNA polymerase II to several glycolysis
genes were decreased in MEFs deﬁcient for Crk and
Crkl. ChIP was conducted with anti-RNA
polymerase II hosphor-S5 CTD repeats (Pol2)
antibody followed by quantitative PCR. Levels of Pol2
association to each gene were expressed as a fold
change. The basal level without induction of Crk;Crkl
deﬁciency set at 1.0 as shown at the red dotted line.
Welch’s t test was performed on delta Ct values of
chromatin IP samples (relative to their respective
DNA input used for IP) between 4-hydroxytamoxyfen
(4OHT)–treated and CTRL groups (n = 3); P-values were 0.0254, 0.0064, and 0.0177 for Gapdh, Pgk1, and Ldha, respectively. (D) Differential Hif1a protein levels were
observed in the nucleus between Crk/Crkl deﬁciency–induced and CTRL MEFs with or without CoCl2 to stabilize Hif1 proteins (box plot). Representative images are
shown on the left to the box plot. MEFs were incubated with or without 0.5 mM CoCl2 for 4 h before ﬁxation. Hif1a proteins were detected in the IN Cell Analyzer 2000
upon immunoﬂuorescent staining with anti-HIF1A antibody. The nuclei were identiﬁed by DAPI staining. Signals in ~2,000–2,300 nuclei were quantiﬁed for each
group for Hif1a nuclear localization. Kruskal–Wallis tests followed by Dunn’s post hoc tests with Bonferroni corrections yielded virtually identical p-levels to that of
Brunner–Munzel tests.

category (p.adj < 1 × 10−10), but not in the up-regulated gene category
(p.adj = 0.964). Pol2 elongation from the TSS downstream beyond +2
kb was also greater for the down-regulated genes in control MEFs
than that of the Crk/Crkl deﬁciency induced MEFs (Fig 5C, the green
versus orange lines in the Pol2 plots). Therefore, down-regulated
mRNA levels (found in RNA-Seq) were generally attributable to
reduced Pol2 transcription initiation and elongation. On the other
hand, up-regulated mRNA expression did not result from elevated
promoter activity. These results demonstrate that Crk/Crkl deﬁciency led to widespread H3K27Ac depression in the epigenome,
leading to marked reduction in de novo transcription of numerous
genes down-regulated as common targets of Crk and Crkl.
Crk/Crkl deﬁciency impairs the effect of glucose on S6K and S6
activation

Semenza, 2010; Chauvin et al, 2014). We found that glucose availability was essential for maintaining active signaling cascades
through Akt, Tsc2, S6K, and S6 in a dose-dependent manner,
whereas 5 mM glucose appeared optimal for Akt S473 phosphorylation as well as Tsc2 T1462 phosphorylation (Figs 6A and S8). Upon
induction of Crk/Crkl-double deﬁciency, glucose resulted in much
muted activation of the cascade compared with that of control MEFs
(Fig 6A). Although Akt S473 phosphorylation was reduced in the Crk/
Crkl-deﬁcient MEFs, glucose-induced Tsc2 T1462 phosphorylation
(considered as an Akt-speciﬁc phosphorylation site) was greater in
the deﬁciency-induced MEFs than that of the control groups. Because the phosphorylation readout was reduced on both p70 S6K
and S6 proteins, these results suggest that intersecting pathways
surrounding Akt and Tsc2 may be dysregulated in Crk/Crkl deﬁciency in response to glucose availability.

The results above demonstrated impaired glycolysis in Crk/Crkl
deﬁciency accompanied by reduced Hif1a protein production.
Signaling pathways known to inﬂuence cell size via p70 S6 kinase
(S6K encoded by Rps6kb1 and Rps6kb2) and the ribosomal protein
S6 (Rps6) are also important for Hif1a translation (Fingar et al, 2002;

Crk/Crkl deﬁciency and glucose restriction lead to cell membrane
blebbing

The CRK family controls glucose metabolism and cell size

https://doi.org/10.26508/lsa.201900635

Imamoto et al.

To provide further evidence for a role that the Crk family may play in
glucose metabolism, we evaluated the effects of 2-deoxy-D-glucose
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Figure 5. Chromatin immunoprecipitation (ChIP)-Seq
analysis.
(A) Scatterplots indicate ChIP-Seq signals for H3K27Ac
and Pol2 (hosphor-S5 CTD repeats) in the x-axis and mRNA
levels (data from RNA-Seq) in the y-axis, in which values
are shown in log2 fold change (log2 FC) as differentials
between Crk/Crkl deﬁciency–induced and uninduced
MEFs. Each dot represents a single gene identiﬁed in
subset “red” (Fig 3B). Red or light-blue dots indicate
down-regulated or up-regulated genes based on their
expression identiﬁed by RNA-Seq, respectively.
Glycolytic genes are labeled for their gene symbols. ChIPSeq signals in these panels are based on peak heights
within transcription start site (TSS) ± 2 kb. Spearman’s
rank correlation coefﬁcient ρ was calculated for the entire
distribution. (B) Boxplots indicate distributions of the ChIPSeq signal differentials within TSS ± 2 kb for H3K27Ac
and Pol2 in either down-regulated or up-regulated
categories of subset “red” genes. Whiskers were drawn
between the highest and lowest data points within 1.5×
interquartile range (IQR) from the upper or lower quartile.
Data points outside the 1.5× IQR are indicated as outliers
(dots). The P-values were calculated by Mann–Whitney
U tests between down-regulated and up-regulated
categories. (C) XY plots indicate the average ChIP-Seq
signals as reads per genome content (RPGC) in the yaxis and the distance from TSS in the x-axis in Crk/Crkl
deﬁciency-induced and uninduced MEFs (KO and CTRL) in
orange and green lines, respectively. Note that when
ChIP-Seq signals are compared in CTRL MEFs between the
down-regulated and up-regulated gene groups, the downregulated group shows greater average peak heights in
both H3K27Ac and Pol2 ChIP-Seq signals. (D) Boxplots
indicate the distribution of the ChIP-Seq signals (RPGC)
within TSS ± 2 kb in Crk/Crkl deﬁciency-induced and
uninduced MEFs (KO and CTRL), for genes downregulated or up-regulated in subset “red.” The y-axis is in a
log10 scale of RPGC. ANOVA and Tukey post hoc tests
were performed on log10-transformed RPGC values to
bring the data distributions closer to Gaussian
distributions. See Fig S7 for boxplots using
untransformed data and square-root transformed data.

A role for Crk and Crkl in IGF1-induced S6K/S6 activation

(2DG), a competitive inhibitor of glucose metabolism, on Crk/Crkl
deﬁcient or control MEFs (Gu et al, 2017). We noted that when
cultured in a glucose-controlled condition (5 mM glucose with 10%
dialyzed FBS), a range of 2DG concentrations induced blebbing cell
morphology identiﬁed by cell staining with CellMask, DAPI, and antivinculin (Fig S9). “Blebbing” is a feature characterized by several
plasma membrane protrusions resembling small beads that decorate the cell edge boundary, as a stage of apoptotic or nonapoptotic processes (Coleman et al, 2001; Fackler & Grosse, 2008).
To minimize the subjective nature of categorical judgment on cell
morphology, we applied an automated computational analysis.
Using a few parameters standardized for blebbing identiﬁcation
(Fig S9), we found that Crk/Crkl deﬁciency exacerbated the blebbing
phenotype induced by 2DG (Fig 6B), thus consistent with their
possible involvement in glucose metabolism. Although the results
do not distinguish apoptotic versus nonapoptotic blebbing, it is
more likely that 2DG-induced blebbing may be an indication of
apoptosis based on the observation that 2DG treatments reduced
the total cell counts in our experimental condition (see the “n”
numbers on top of each bar in Fig 6B).

Insulin-like growth factor 1 (Igf1) is one of the growth factors required for normal development and known to control cell size
through Akt (Lloyd, 2013; Manning & Toker, 2017). Igf1 signaling was
implicated in our global analysis of the RNA-Seq results (Fig 3A),
and Igf1 was one of the up-regulated DE genes in subset “red” in Fig
3B (see also Supplemental Data 1). Real-time quantitative RT-PCR
using two non-overlapping sets of Igf1-speciﬁc primers conﬁrmed
that steady-state Igf1 mRNA levels were increased nearly 10-fold
upon induction of Crk/Crkl double deﬁciency compared with the
MEFs without deﬁciency induction (Fig 6C). Despite this upregulated Igf1 expression, Crk/Crkl double deﬁciency–induced
MEFs exhibited muted responses to IGF1 for activating S6K and S6
(Fig 6D). These results demonstrate that Crk/Crkl deﬁciency uncouples the autocrine/paracrine growth factor Igf1 from transducing S6KS6 activation. Interestingly, however, Crk/Crkl deﬁciency did not inhibit
Igf1-induced Akt S473 phosphorylation, suggesting that Igf1 was able to
activate MTORC2 complex. In addition, overexpression of Crk or Crkl by
itself increased both phosphorylation and protein levels of S6 in
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Figure 6. Deﬁciency for Crk and Crkl results in
aberrant glucose metabolism and Igf1 signaling.
(A) Glucose availability in culture media throttled dosedependent phosphorylation of ribosomal protein S6
(pS6-S240/244), as well as that of Akt (pAKT-S473),
TSC2 (pTSC2-T1462), and p70 S6 kinase (pS6K-T389) as
shown in immunoblots. MEFs were cultured with
indicated concentrations of glucose for 24 h after a
24-h period of glucose restriction at a concentration of
0.1 mM, the lowest glucose concentration that MEFs can
tolerate in the presence of 10% dialyzed FBS (Fig S8).
As a point of reference, basal DMEM includes 5 mM
glucose, whereas a high-glucose formula includes
25 mM glucose. (B) The glucose metabolism inhibitor
2-deoxy-D-glucose (2DG) induced a cell blebbing
phenotype in a dose-dependent manner, and Crk/Crkl
deﬁciency signiﬁcantly exacerbated the frequency of
the phenotype in single cell analysis. The 2DG
concentrations are indicated under the x-axis. The
frequency of the blebbing phenotype was
determined as described in the Materials and Methods
section and Fig S9. Large numbers of cells (n) were
imaged in a high-content imaging apparatus, and
individual cells were analyzed through a series of
MATLAB scripts. Beneath the bar graph is a matrix table
for P-values by Fisher’s exact tests adjusted for
multiple comparisons (FDR). (C) Crk/Crkl deﬁciency
increased Igf1 mRNA levels. The bar graph represents
levels of Igf1 messages upon Crk/Crkl deﬁciency
induction in MEFs, relative to that of their controls
without deﬁciency induction. As a control, fold change
of Rplp0 (60S ribosomal protein p0) is also shown.
Two non-overlapping primer sets 1 and 2 (ps1 and ps2)
were used to conﬁrm up-regulation approximately at an
order of magnitude greater. Error bars indicate
standard deviations (n = 3). Red-dotted line shows the
level in control samples set at a relative fold change of 1.
(D) Crk/Crkl deﬁciency resulted in muted response to
exogenous Igf1 over a range of doses in
phosphorylation of p70 S6 kinase (S6K) and ribosomal
protein S6. In contrast, Akt phosphorylation was induced by Igf1, suggesting a role of Crk and Crkl in a regulatory mechanism on S6K and S6. MEFs were cultured without
serum for the last 3 h of 48 h post deﬁciency induction, then were stimulated with Igf1 at different concentrations indicated for 15 min. (E) Crk and Crkl played an important
role in S6K and S6 phosphorylation on which both Igf1 and ﬁbronectin (FN) cooperate as shown in immunoblots probed with different antibodies. Note that FN alone did
not activate Akt (as seen in pAkt-S473), whereas Igf1 did. After 3 h serum starvation, MEFs were re-plated on FN or poly-L-lysine in serum-free medium for 60 min
followed by incubation with Igf1 for 15 min before harvest.

HEK293 cells, whereas little effects were observed on p70S6K (Fig S10).
Because p70S6K lies upstream of S6, these results suggest the possibility that Crk and Crkl may play a role in Igf1-induced S6K and S6
activation in addition to the canonical Akt-mediated pathway, while
also implicating Crk and Crkl in a mechanism by which they may
activate S6 independent of p70S6K.
Cooperative signaling between Igf1 and integrins
Crk and Crkl are involved in a broad range of signaling pathways
associated with tyrosine kinases (Feller, 2001; Birge et al, 2009).
Among them are pathways mediated by extracellular matrix (ECM)
proteins and integrins. We, therefore, investigated pathway integration
between Igf1 and the ECM protein ﬁbronectin (FN) for activating
p70S6K and S6 in MEFs (Fig 6E). Among the deﬁciency-uninduced
control groups (Fig 6E left half, the CTRL lanes), Igf1 induced
phospho-Akt S473 in 15 min at comparable levels between the polyL-lysine or FN groups (PLL or FN, respectively), whereas neither PLL
nor FN induced Akt phosphorylation without Igf1. We noted that
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without Igf1, phosphorylation of S6 (S240/244) and S6K (T389) was
increased by plating on FN compared with that of PLL, thus the
ability of FN to increase phosphorylation of S6 and S6K appears to
be independent of Akt. When Igf1 stimulated the MEFs plated on FN,
the phosphorylation levels on S6 and S6K was highest among the
uninduced groups. Among the deﬁciency-induced groups (Fig 6E
right half, the 4OHT lanes), we observed that although the general
trend is similar to the deﬁciency-uninduced control groups (the
CTRL lanes), the levels of S6 and S6K phosphorylation decreased in
the 4OHT groups for their responses to Igf1 and FN, independently
or combined. These results demonstrate an important role of Crk
and Crkl in mediating cooperative signals to S6K and S6 activation
from Igf1 and FN.
Rescue of Crk/Crkl deﬁciency by an activated Rapgef1
Rapgef1 (also known as C3G) encodes a guanine–nucleotide exchange factor for the small G-protein Rap1 (encoded by Rap1a and
Rap1b) as one of the major proteins to which the SH3n domain of
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Our present study has demonstrated that compound heterozygosity of Crk and Crkl (loss of shared functions) as well as individual
gene disruption can generate developmental defects in mice, part
of which resemble DiGeorge anomaly in multiple aspects, despite
the fact that CRK is not a 22q11 gene. Furthermore, Tbx1 genetic
interaction with not only Crkl but also with Crk provides evidence
for a possible functional intersection among these genes. We have
demonstrated that normal mesoderm requires at least 50% of the
Crk family-combined dosage (Fig 1). It is noteworthy that Tbx1 is
essential in the mesoderm for normal heart and outﬂow tract
development, whereas Tbx1 expression is also required in the
epithelia of ectoderm or endoderm origins for normal fourth arch
artery and thymic development (Zhang et al, 2006). Tbx1 knockdown
in a cardiomyocyte-differentiating P19 subline as well as Tbx1mutant embryos show abnormal histone H3 monomethyl-K4 proﬁles (Fulcoli et al, 2016). It is also noteworthy that Tbx1 deﬁciency
causes DE in mTOR signaling pathway, VEGF signaling pathway,
phosphatidylinositol signaling pathway and focal adhesion (Fulcoli

et al, 2016), which we have also identiﬁed as Crk/Crkl-shared
pathways in this study (Fig 3A and C). In fact, Tbx1 knockdown results
in a reduced number/size of focal adhesions in C2C12 cells (Alfano
et al, 2019), in similar ways to Crk/Crkl-deﬁcient MEFs, we analyzed
in this study (Fig 7). Taken together, Crk, Crkl, and Tbx1 may regulate
the gene regulatory network by modulating global epigenetic
landscape, which directly or indirectly control cell behavior through
cell–matrix adhesion and metabolism.
Our results have implicated Crk and Crkl in glucose metabolism
through the transcription factor Hif1a. Whereas hypoxic conditions
are known to increase Hif1 protein levels by stabilization, Hif1a is
essential for developmental processes under physiological oxygen
levels of 2–9% O2 in mouse embryos (Carmeliet et al, 1998; Iyer et al,
1998; Ryan et al, 1998). Furthermore, Hif1a is required for normal
expression of several glycolytic enzyme genes such as Glut1, Pfkl,
Aldoa, Tpi1, Gapdh, Pgk1, and Ldha under the ambient oxygen level
as well as in 1% O2 in mouse embryonic stem (ES) cells (Iyer et al,
1998; Ryan et al, 1998). Therefore, impaired Hif1a protein production
may be attributable to reduced glycolysis gene expression in Crk/
Crkl-deﬁcient MEFs, although investigated in the ambient oxygen
level (Fig 4). Many MTORC1-inducible genes have been identiﬁed
with Hif1- and Myc-binding sites, whereas Hif1a is essential for
MTORC1-dependent glycolytic gene expression (Düvel et al, 2010). It
was also reported that Myc stabilizes HIF1a post-translationally and
that Myc-induced transformation requires Hif1a in the human
immortalized mammary cell line IMEC in normoxia (Doe et al, 2012).
We noted that Myc was one of the down-regulated genes in subset
“red,” and our ChIP-Seq results also indicated reduced association
of H3K27Ac and Pol2 markers with Myc in Crk/Crkl-deﬁciency induced MEFs (Supplemental Data 2 and Fig S12).
Vascular endothelial growth factor A (VEGFA) is one of the targets
of Hif1 (Forsythe et al, 1996). It has been reported that IGF1 can
stimulate VEGFA mRNA expression by stabilizing HIF1A protein in
human colon cancer cell line HCT116 (Fukuda et al, 2002). We noted
that Vegfa was down-regulated in subset “red,” thus commonly
affected by Crk and Crkl (Supplemental Data 2). Analysis of the ChIPSeq signals around the Vegfa gene revealed that its promoterproximal region was poorly associated with H3K27Ac and Pol2 CTD
phospho-S5, thus indicating that Vegfa promoter activity was
suppressed in Crk/Crkl-deﬁcient MEFs (Fig S12). Although Igf1 deﬁciency has not been linked to DiGeorge-like anomaly in humans or
in animal models, a positive role for Igf1 has been demonstrated in
promoting mesoderm development and vasculogenesis in mouse
embryoid bodies (Piecewicz et al, 2012). Vegfa is known as a dosagesensitive gene for normal development and Vegfa164-isoform deﬁciency results in DiGeorge-like anomaly in mice (Carmeliet et al,
1996; Ferrara et al, 1996; Stalmans et al, 2003). Reduced vegfa also
shows genetic interactions with Tbx1 knockdown in zebraﬁsh
(Stalmans et al, 2003). Therefore, reduction of Vegfa expression may
also contribute to an impaired genetic network in which Crk and
Crkl may have common intersection with Tbx1.
In this study, we have focused on the genetic and epigenetic
network down-regulated in Crk/Crkl deﬁciency because up-regulated
genes found in RNA-Seq may not be effectively translated into increased protein productions because of suppressed p70S6K/S6 activities in Crk/Crkl-deﬁcient MEFs. Although this study did not
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Crk and Crkl can associate (Feller, 2001; Birge et al, 2009). Rapgef1 is
ubiquitously expressed during early-mid gestation mouse embryos
and its genetic ablation results in an early embryonic phenotype at
E7.5, whereas a hypomorphic mutation generates a vascular phenotype around E11.5-E14.5 (Ohba et al, 2001; Voss et al, 2003). These
reports also demonstrated that Rapgef1 is an important mediator of
cell adhesion to ECM proteins associated with reduced numbers of
focal adhesions in MEFs isolated from the mutant embryos. We
found that an activated Rapgef1 (C3GF) conferred MEFs resistance
to Crk/Crkl deﬁciency for cell size (Fig 7A). C3GF also rescued Crk/
Crkl-deﬁcient MEFs for cell proliferation (Fig 7B) and restored expression of some glycolysis enzyme genes that were down-regulated
in Crk/Crkl deﬁciency (Fig 7C). Crk/Crkl deﬁciency–induced reduction
of fructose-1,6-bisphosphate (F1,6P2) was also restored by C3GF (Fig
7D). C3GF increased S6 and S6K phosphorylation, accompanied by
elevated Akt phosphorylation (Fig 7E). Interestingly, C3GF by itself
elevated tyrosine phosphorylation and protein levels of p130Cas/
Bcar1, events thought to be upstream of Rapgef1, compared with
that of the vector control groups. Likewise, C3GF enhanced focal
adhesions as identiﬁed by subcellular localization of total phosphotyrosine, phosphorylated p130Cas/Bcar1, and the Fak. On the
other hand, Crk/Crkl-deﬁcient MEFs in the vector control group
appeared to have fewer focal adhesions (Fig 7F). As cells exhibited
varying numbers of focal adhesions in each group, evaluating a
small number of cells may introduce unintended bias. To objectively quantify focal adhesions in a large number of cells, we
adopted an automated image analysis (Fig S11). As anticipated,
whereas the number of focal adhesions was reduced by Crk/Crkl
deﬁciency, C3GF expression normalized focal adhesion counts (Fig
7G). These results conﬁrmed not only the role of Rapgef1 in mediating positive-feedback signals from Crk and Crkl but also its
important functions in glucose metabolism and cell size/adhesion
homeostasis.

Discussion
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Figure 7. An activated Rapgef1 partially rescues aspects of Crk/Crkl deﬁciency in MEFs.
(A) Overexpression of C3GF partially blocked Crk/Crkl-deﬁciency–induced cell size changes. The histograms show distributions of cell sizes as estimated by FSC-H
measurements in FACS analysis of ~6,000–7,000 cells in the G1 phase in each group. To compare the distributions, a boxplot was generated below the histograms. Human
RAPGEF1 fused to a farnesylation sequence (C3GF) or empty vector was introduced into MEFs before Crk/Crkl deﬁciency induction by 4OHT. Two-way ANOVA followed by
Tukey post hoc tests were performed for statistical comparisons. (B) Overexpression of C3GF rescued Crk/Crkl deﬁciency–induced inhibition of cell proliferation. Cell
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investigate precise mechanisms that underlie the abnormal cell
contact behavior (Fig 2B–D), a recent study reported that normal CIL
relies on Fak and Src for coordinated redistribution of cell–matrix
contacts and intracellular force in frog neural crest cells (Roycroft
et al, 2018). Because Crk and Crkl mediate signals partly from Fak and
Src (Shin et al, 2004; Birge et al, 2009; Watanabe et al, 2009), it is
plausible that Crk and/or Crkl are also required for traction force
redistribution, a key mechanism for repulsive locomotion as an
essential feature of mesenchymal cells. In this regard, it is noteworthy that Crk/Crkl deﬁciency inhibits focal adhesions functionally
and structurally (Figs 3A and C and 7F and G). Focal adhesions include
several mechanosensor proteins such as the Crk/Crkl SH2-binding
protein p130Cas (Bcar1), and the small G-protein Rap1 has been
identiﬁed as a critical participant in mechanotransduction and
mechanosensing (Sawada et al, 2006; Lakshmikanthan et al, 2015;
Freeman et al, 2017). Because an activated mutant of the Crk/Crkl
SH3-binding protein Rapgef1 (C3G) rescues Crk/Crkl deﬁciency for
glycolysis, cell proliferation, and focal adhesions in MEFs (Fig 7), the
Crk/Crkl-Rapgef1-Rap1 axis is a modular pathway which senses
multiple extracellular signals such as Igf1 and integrin-dependent
mechanotransduction. While Crk/Crkl deﬁciency exacerbated the
blebbing phenotype induced by 2DG, the phenotype was different
from the focal adhesion phenotype in Crk/Crkl-deﬁcient MEFs (Figs
6B and 7F and G). Because activation of Rapgef1-rescued cell size/
glucose metabolism as well as focal adhesions in Crk/Crkl deﬁciency, it is tempting to hypothesize that glucose metabolism may
be regulated downstream of focal adhesions/cell–matrix adhesion.
It is also noteworthy that delayed postnatal growth is common
among DGS/22q11.2DS patients (McDonald-McGinn et al, 2015). A
recent study has reported that a 22q11.2DS patient with a small
statue had growth-hormone and IGF1 deﬁciency (Bossi et al, 2016).
Therefore, impaired responses to IGF1 that we found in MEFs may
also have clinical relevance. In addition, although the number of
reported cases are relatively few, maternal diabetes has been
linked to thymic and kidney defects associated with tetralogy of
Fallot and other congenital disorders in infants without a deletion
in 22q11.21 (Novak & Robinson, 1994; Digilio et al, 1995; Cirillo et al,
2017; Taliana et al, 2017). We speculate that maternal glucose
metabolism may be a possible contributing factor that could partly
explain large variations of penetrance and expressivity observed
among 22q11.2DS patients. Future studies are warranted to investigate
the mechanisms by which the cell-adhesion signaling axis involving
Crk/Crkl, and Rapgef1 regulates the epigenetic network important for

metabolism and proper development of tissues affected in DiGeorge/
22q11.2DS patients.

Materials and Methods
Generation of Crk conditional knockout mice
The mouse Crk gene was targeted in an 129S6-derived ES cell line
using a homologous recombination vector assembled using genomic fragments isolated from an 129-derived genomic library as
well as FRT-PGKneo-FRT (FneoF) and loxP sequences as illustrated
in Fig S1. Targeted ES cells were injected into C57BL/6J blastocysts to
generate chimeric mice via standard technique in the Transgenic
and ES Cell Technology Mouse Core Facility at the University of
Chicago. Highly chimeric animals were then backcrossed with
C57BL/6J. The PGKneo cassette was removed by a cross with the
FLPeR mice (B6.129S4-Gt(ROSA)26Sortm1(FLP1)Dym). Mice heterozygous
for Crk and FLPeR was then backcrossed with C57BL/6 to segregate
out FLPeR. Crk heterozygous mice without neo or ﬂp were then
selected as a knockout-ready strain, Crk f (Crk-ﬂoxed exon 1; B6.129S4Crktm1.1Imo/J). We previously generated and reported a Crkl conditional
strain (B6;129S4-Crkltm1c(EUCOMM)Hmgu/ImoJ) (Haller et al, 2017; LopezRivera et al, 2017). To make distinction easier from Crk f, we call the Crkl
knockout-ready strain Crkl f2 because Crkl exon 2 is ﬂanked by two loxP
sites. After more than ﬁve generations of backcross with B6, some
Crk f/+ and Crkl f2/+ mice were crossed with R26 Cre-ERT2 strain
(B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J) or with Mesp1Cre (Saga et al, 1999)
to set up 4-hydroxytamoxifen (4OHT)-inducible or mesoderm-speciﬁc
knockouts, respectively. For some experiments, Crkd or Crkld2 (deletion
of Crk exon 1 or Crkl exon 2, respectively) was generated as a knockout
allele by crossing the knockout-ready strains and a global-deletion
strain, Meox2Cre (B6.129S4-Meox2tm1(cre)Sor/J) (Tallquist & Soriano,
2000). Meox2Cre was then segregated out by backcross with C57BL/
6J, and Crkd and Crkld2 heterozygous mice were maintained by continual backcross with C57BL/6J. In some experiments, Crkd were
crossed with Tbx1− heterozygotes (a gift from Virginia Papaioannou)
had been maintained by continual backcross with C57BL/6J more than
11 generations. Mouse embryos were isolated at various stages of
development by timed mating. Mice and embryos were genotyped
using PCR primers listed in Table S3. All mouse works were carried out
in strict accordance with the protocols approved by the Institutional
Animal Care and Use Committee of the University of Chicago.

numbers were counted in tissue culture plates for 3 d after plating. Bars indicate standard deviations from triplicate determinations (n = 3). Two-way ANOVA followed by
Tukey post hoc tests were performed for statistical comparisons. (C) C3GF restored expression of the glycolytic enzyme genes. Expression of glycolytic genes were
determined in real-time/quantitative RT-PCR. Bars indicate standard deviations. Two-way ANOVA followed by Tukey post hoc tests were performed on raw Ct values (n = 3).
(D) C3GF blocked Crk/Crkl deﬁciency from reducing the level of fructose-1,6-bisphosphate (F1,6P2). Bars indicate standard deviations from triplicate determinations
(n = 3). Two-way ANOVA followed by Tukey post hoc tests were performed for statistical comparisons. (E) Immunoblots show C3GF-dependent rescues on S6, S6K, and Akt
phosphorylation associated with elevated phosphorylation of the focal adhesion protein p130Cas (Bcar1). (F) C3GF restored phosphorylated Bcar1, phosphotyrosine, and
Fak localization at focal adhesions. Representative ﬂuorescent microscopy images are shown. (G) Violin plots show quantitative results of focal adhesions. Focal
adhesions were identiﬁed by localization of Fak in immunostained MEFs followed by automated image acquisition and analysis as described in the Materials and Methods
section (also see Fig S11). The sample size (the number of cells per group) was 1,481, 516, 1,666, and 1,374 in a 2X2 experimental design (Uninduced/Vector Only, 4OHTInduced/Vector Only, Uninduced/C3GF, and 4OHT-Induced/C3GF groups, respectively) after applying the cutoffs indicated in Fig S11 to minimize the possibility of
counting artifacts in staining and segmentation. However, inclusion of all cells without cutoffs did not affect the statistical outcome. Statistical analysis was performed by a
global pseudo rank method with Tukey tests adjusted for multiple comparisons using the mctp function in the nparcomp package written in the programming language R
(Konietschke et al, 2015). Similar statistical outcome was obtained by two-way ANOVA after log10-transformation (Fig S11D). White circles in each violin plot indicate the
position of the median.
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RNA in situ hybridization
Anti-sense RNA probes were generated from pBluescript plasmids
that included ~700-bp fragments isolated from the 39 UTR of mouse
Crk and Crkl cDNAs. The full-length cDNAs were synthesized by RTPCR using oligo(dT) and gene-speciﬁc 59 UTR primers using total
RNA isolated from C57BL/6J E10.5 embryos. The cDNA sequences
were conﬁrmed by low-throughput Sanger sequencing from
plasmid primers. RNA in situ hybridization was carried out in E10.5
mouse embryos isolated from C57BL/6J mice as previously described (Guris et al, 2006).
MEFs
Primary MEFs were isolated from individual embryos at E11.5 and
cultured in DMEM high-glucose formula supplemented with 0.1 mM
2-mercaptoethanol and 10% fetal bovine serum (HyClone) as previously described (Li et al, 2002). Embryos and MEFs were dissociated
using Accutase or TrypLE (Thermo Fisher Scientiﬁc). MEFs were split 1:3
for maintenance every 3 d. Cre-mediated gene deﬁciency was induced
by 0.25 μM (Z)-4-hydroxytamoxifen (Sigma-Aldrich) for 24 h in MEFs
having a genetic background of R26 Cre-ERT2, and then washed and
replated 1:3 into new plates. Cells were harvested 48 h after removal of
4OHT as deﬁciency-induced MEFs for experiments, unless otherwise
indicated. In some experiments, glass coverslips or culture plates were
coated with 0.1% gelatin (porcine skin, Sigma-Aldrich), ﬁbronectin
(bovine plasma; Sigma-Aldrich), or poly-L-lysine (Sigma-Aldrich) before experimental replating.
For some experiments, MEFs were stimulated with recombinant
human IGF1 (291-G1; R&D Systems) for 15 min after a short serum
starvation period of 3 h (longer serum-free starvation caused apoptosis in Crk/Crkl double-deﬁcient cells). To determine the effect of
medium glucose concentrations, MEFs were incubated with glucosefree DMEM supplemented with various concentrations of glucose
and 10% dialyzed FBS after glucose deprivation down to 0.1% for 24 h.
The starvation concentration of glucose was determined as shown in
Fig S8.
For measurements of cell spreading, MEFs were dissociated with
Accutase and suspended in serum-free DMEM, then plated on gelatincoated plates at a low density so that most cells do not contact each
other. Cells were ﬁxed at each time point, and only adherent cells were
pictured under a 10× objective after wash. The number of pixels that
each cell occupied were determined in eight most spread cells selected per ﬁeld in three randomly selected ﬁelds per plate, in three
plates per time point per group using ImageJ (thus, each data point
represents a collection of data from a total of 72 cells).
To estimate cell size, light scatters (FSC-H, FSC-A, SSC-H, and SSCA) were measured in a ﬂuorescence-activated cell sorting machine
(FACS Canto II; BD Bioscience), after ﬁxing cells with ethanol and
stained using PI/RNase staining buffer (550825; BD Pharmingen).
~6,000 or more cells were measured in each group.
Transfection and viral transduction
To transfect or infect MEFs for transducing exogenous transgene
expression, primary MEFs were kept on the 3T3 protocol until their
proliferation was easily maintained and, therefore, considered
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spontaneously immortalized (passage 15 or greater). To generate
MEFs that express an activated RAPGEF1 (C3G), a full coding sequence of human C3G fused to the RAS farnesylation site (C3GF, a
gift from Michiyuki Matsuda) was subcloned into pMX-ires-GFP
vector for retrovirus production (pMX-C3GF-ires-GFP). Ecotropic
retrovirus was generated in Plat-E packaging cells and used to
infect immortalized MEFs per standard protocols. Control MEFs
were generated with pMX-ires-GFP without C3GF. GFP-positive cells
were then selected by FACS and maintained for experiments. In
some experiments, in-frame fusions of EGFP and human CRK or
CRKL was constructed using pEGFPC2 plasmid (Clontech-TAKARA).
Human embryonic kidney 293 cells were transfected with the plasmid
to overexpress EGFP-CRK or CRKL using Lipofectamine LTX (Invitrogen)
as recommended in the manufacturer’s protocol.

Immunoﬂuorescence staining
For detection of Hif1a proteins, MEFs induced for Crk/Crkl deﬁciency
were replated in 96-well plates at a density of 4 × 104 cells/well 24 h
before harvest (the time of harvest was 72 h from the time 4OHT was
added as described above). Some cells were treated with CoCl2 at a
ﬁnal concentration of 0.5 mM for 4 h before ﬁxation with 2%
paraformaldehyde. Cells were permeabilized with 0.1% Triton X-100
for 5 min and blocked with 10% FBS and Blocking One (Nacalai).
Hif1a was detected with mouse monoclonal anti-Hif1a antibody
clone H1alpha67 (NB100-123; Novas) and goat anti-mouse IgG
conjugated with Dylight 549 (Thermo Fisher Scientiﬁc). Nuclei were
counter-stained with DAPI. Fluorescent signals were detected in IN
Cell Analyzer 2000 (GE Healthcare).
For staining other cellular proteins, MEFs were replated on glass
coverslips coated with 0.1% gelatin. 24 h after replating, MEFs were
ﬁxed for 15 min with 4% paraformaldehyde, 1.5% BSA fraction V, and
0.5% Triton X-100 in 1× CB cytoskeletal buffer (10 mM MES, pH 6.8, 3
mM MgCl2, 138 mM KCl, and 2 mM EGTA). After three washes, the
cells were incubated with the primary antibody (mouse monoclonal
anti-FAK, clone 4.47, 05-537; EMD-Millipore; rabbit anti-p130CAS
phospho-Y249, #4014; Cell Signaling Technology; or mouse monoclonal anti-phosphotyrosine, 4G10, 05-321; EMD-Millipore) diluted 1:
200 in 1× CB buffer containing 1.5% BSA and 0.5% Triton X-100 for 1 h.
After three washes, the cells were incubated with a Dylight 550–
conjugated secondary antibody (Thermo Fisher Scientiﬁc) that matches
the species speciﬁcity of the primary antibody diluted 1:1,000 in 1×
CB buffer containing 1.5% BSA and 0.5% Triton X-100 for 1 h. F-actin
and nuclei/DNA was stained with Alexa Fluor 647 phalloidin and
DAPI (Thermo Fisher Scientiﬁc) according to a standard staining
method. Stained cells were mounted in Prolong Gold Antifade
(Thermo Fisher Scientiﬁc) and observed under a 60× oil objective
lens in DeltaVision Elite deconvolution microscope system (GE
Healthcare). In some experiments, MEFs were replated with or
without induction of Crk/Crkl deﬁciency in a gelatin-coated 96-well
plate and stained as above for high-throughput image acquisitions
in IN Cell Analyzer 2500HS (GE Healthcare). For such experiments,
additional counterstaining was performed using HCS CellMask
Deep Red (Invitrogen/Thermo Fisher Scientiﬁc) for identiﬁcation
and segmentation of the cell body (see also the Automated Image
Analysis section below).
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Immunoblot

Metabolome analysis

Cell lysates were prepared with lysis buffer containing 1% NP-40 (or
IGEPAL CA-630), 50 mM Tris pH 7.5, 10% glycerol, 0.2 M NaCl, 2 mM
MgCl2, cOmplete protease inhibitor cocktail (Roche) and PhosSTOP
(Roche). Immunoblots were prepared on Immobilon-P membrane
(EMD-Millipore) after electrophoresis in SDS-polyacrylamide gel
(7.5–15% gradient) using a standard protocol. Proteins were then
detected using the following primary antibodies: anti-phospho-S6
S240/244 (#2215; Cell Signaling Technology), anti-S6 (CST#2217),
anti-phospho-p70 S6K T389 (CST#9205), anti-p70 S6K (CST#9202),
anti-phospho-AKT S473 (CST#4060), anti-pan AKT (CST#2920), antiphospho-TSC2 T1462 (CST#3617), anti-TSC2 (CST#3990), anti-phosphop130CAS Y247 (CST#4014), anti-p130CAS (BD 610272), anti-CRK (BD 610035),
anti-CRKL (05-414; EMD Milllipore), and anti-C3G (sc-15359; Santa Cruz
Biotechnology). Using a horseradish peroxidase–conjugated secondary antibody matching the species of the primary antibody,
chemiluminescence was detected on the immunoblot in ImageQuant LAS4000 (GE Healthcare).

Cellular metabolites were analyzed by CE-TOFMS using primary
MEFs for Crk or Crkl single gene deﬁciency and Crk/Crkl double
deﬁciency as well as their uninduced controls as previously described (Uetaki et al, 2015). Results obtained from three independent
samples were compared for each genotype between deﬁciencyinduced and uninduced MEF groups using Welch’s t test for each
metabolite (P < 0.05).

RNA-Seq
RNA-Seq analysis was conducted using total RNA isolated from
primary MEFs. Four embryos were isolated for each genotype (Crk f/f,
Crkl f2/f2, Crk f/f;Crkl f2/f2, or wild-type; all compound heterozygous
for R26creERT2) as four independent samples per genotype, with an
exception that we isolated only two wild-type embryos as negative
control samples. When cells were subconﬂuent, each cell lot was
then induced or uninduced for deﬁciency with 4-hydroxytamoxifen
for 24 h, then replated on to new plates without 4OHT to expand for
48 h before harvest. Total RNA was isolated using a Qiaquick RNA
isolation kit as described in the manufacturer’s protocol. The
quality of isolated RNA was checked in a 2100 Bioanalyzer (Agilent
Technologies). RNA sequencing was performed in an Illumina HiSeq
2000 with paired end reads. The average inner fragment size was
~250 bp. The sequence reads were ﬁltered by PRINSEQ version
0.20.4 for sequence data quality control (Schmieder & Edwards,
2011), then mapped to the mouse genome sequence in GRCm38.p3
using Tophat2 (version 2.1.0) with the following parameters: –mateinner-dist 250 –mate-std-dev 40 (Kim et al, 2013). Aligned read
counts assigned to RefSeq annotations were obtained by the
featureCounts (version 1.4.6) function of Rsubread (Liao et al, 2014)
and analyzed by DESeq2 version 1.12.4 (Love et al, 2014). As each lot
of primary MEFs were traceable with or without 4OHT treatment,
pairwise comparisons were performed in each individual MEF
for evaluating DE with or without the effects of cre-induced
recombination.
Pathway analysis
We used the DE genes identiﬁed in RNA-Seq analysis above (FDR <
0.05) using Ingenuity Pathway Analysis (QIAGEN) or KEGG. KEGG
annotations were added using the R package clusterProﬁler (Yu
et al, 2012). Mapped KEGG enrichments were visualized using
FuncTree (Uchiyama et al, 2015) available at https://bioviz.tokyo/
functree/.
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ChIP and ChIP-Seq
MEFs induced Crk/Crkl deﬁciency were harvested 30 h after removal of 4OHT, along with control MEFs treated with vehicle instead
of 4OHT. Samples were prepared using SimpleChIP Plus Enzymatic
Chromatin IP Kit (#9005; Cell Signaling Technology) as recommended in the manufacturer’s protocol. Antibodies used were
anti-histone H3 acetylated lysine 27 rabbit polyclonal antibody
(ab4729; Abcam) and anti-RNA polymerase 2 CTD repeat YSPTSPS
(phospho-S5) mouse monoclonal antibody (clone 4H8, ab5408;
Abcam). For immunoprecipitation, Dynabeads protein G or M-280
sheep anti-mouse IgG (Thermo Fisher Scientiﬁc) was used to best
match the species range and speciﬁcity for each primary antibody.
For quantitative analysis of selected glycolysis genes, Pol2 ChIP
samples were used for real-time PCR using SYBR Green with the
primer pairs listed on Table S3. For ChIP-Seq experiments, highthroughput sequencing was conducted in an Illumina HiSeq 2500
for 36-bp single end reads. All ChIP-Seq data were ﬁrst processed
with Cutadapt and FastQC under the wrapper software Trim Galore
v0.4.4 with the “-q 30” option in Cutadapt to trim off low quality
ends (https://www.bioinformatics.babraham.ac.uk/projects/
trim_galore/). The sequence output was then aligned to the mouse
reference genome GRCm38.p3 using Bowtie v1.1.2 with the “-m 1”
option (Langmead et al, 2009). Duplicates were removed from
aligned reads using PICARD v1.14 (https://broadinstitute.github.io/
picard/). The mapped reads were then standardized for each experiment to an effective mouse genome size of 2,652,783,500 bases
as “reads per genome coverage or content” (RPGC) using the utility
package deepTools v2.1.1 (Ramı́rez et al, 2016). Utilities in deepTools
were also used for downstream analysis of normalized ChIP-Seq
results. ChIP-Seq results were normalized against the background
signals obtained from whole cell extracts for corresponding cell
groups.
Automated image quantiﬁcation
Image segmentation was performed using a custom MATLAB script
(available upon request; MATLAB is a programming language
available from Mathworks). First, we acquired a set of images of
CellMask, DAPI, and anti-vinculin (or anti-FAK) staining to segment
the cells, nuclei, and focal adhesions, respectively, under a 40×
objective lens equipped in IN Cell Analyzer 2500HS (GE Healthcare).
We used a previously published method based on phase stretch
transform to segment nuclei and focal adhesions (Asghari & Jalali,
2015), while performing empirical optimizations of the input parameters. To segment the cells, we ﬁrst smoothed the images and
used a threshold based on the average intensity of the dimmest
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20% of pixels in the CellMask channel corresponding to background
pixels. We used the DAPI staining to determine if any segmented
regions contained multiple nuclei corresponding to under-segmented
regions. These regions were re-segmented with a higher threshold
and expanded by region growing. The intersection of these expanded
regions was used to segment this larger region into single cells. After
this step, we removed any remaining regions with 0 or multiple nuclei.
We noticed that blebbing cells consistently showed rough cell
boundaries having bead-like bulging membrane protrusions with
high curvatures, small cell/nuclear area ratio, and a high cytoplasmic
intensity of vinculin signals relative to that of the nucleus. To estimate
the boundary curvature for each single cell, we ﬁrst performed
smoothing edge boundaries by Savitzky–Golay ﬁlter (Diederick, 2019).
An instantaneous curvature was estimated for each set of neighboring
points using a code deposited at the MATLAB Central File Exchange
(Mjaavatten, 2019), where the curvature is deﬁned as 1/ri (ri is the
radius for a point, Pi). To standardize threshold parameters, we analyzed ﬁve randomly selected images from each group (2-by-2 groups:
with or without 3 mM 2DG× with or without Crk/Crkl deﬁciency induction) and manually identiﬁed blebbing and non-blebbing cells
among the segmented cells (Fig S9). In automated analysis, the cells
were then ruled “blebbing” when they have a combination of the three
standardized threshold parameters: an average single-cell curvature
larger than 0.029 pixel−1, a ratio of nuclear to cytoplasmic vinculin
intensity <1.15, and a cell/nuclear area size ratio <4.5 (Fig S9). Using
these standardized parameters, “blebbing” cells were then identiﬁed
in a total of 7,409 MEFs segmented (Fig 6B). As some cells appear to be
outliers (blue arrows in Fig S9B), we ﬁltered out the cells having the
DAPI-positive area size smaller than 1,000 pixels or with the cell area
greater than 150,000 pixels, whereas the median nuclear and cell area
sizes were 8,638 and 35,665 pixels, respectively. The ﬁltering process
removed 809 cells and 148 cells from analysis, respectively.
For quantiﬁcation of focal adhesions, we used the cell and
nuclear segmentations to remove noise from our focal adhesion
segmentation by ruling out segmentation outside the cells or inside
the nucleus. We further reﬁned the focal adhesion selection by
removing areas smaller than 30 pixels or lower intensity than the
cell average staining intensity. We conﬁrmed that differences in the
number of focal adhesions segmented in each condition could not
be attributed to systematic differences in rates of segmentation
errors for different image sets (Figs 7G and S11).
Resources
The knockout-ready Crk conditional strain will be available through
the Jackson Laboratory (JAX Stock #032874). The RNA-Seq and ChIPSeq data have been deposited to the DDBJ (www.ddbj.nig.ac.jp) and
have been assigned the accession numbers DRA007302 and
DRA007305, respectively. The deposited read data will be available
via the BioProject page at NCBI as the BioProjects PRJDB7421 and
PRJDB7413, respectively (www.ncbi.nlm.nih.gov/bioproject/).

Acknowledgements
The authors thank VE Papaioannou for the Tbx1 null strain, P Soriano for the
Meox2cre and R26FLPeR strains, Y Saga for the Mesp1cre strain, M Matsuda for
the C3G-F plasmid, L Degenstein and The Transgenic and ES Cell Technology
Core for assisting generation of the Crk conditional mutant strain. This work
was supported in part by research grants from JSPS (17H06299, 17H06302, and
18H04031), the Nagase Science Technology Foundation, and Astellas
Foundation for Research on Metabolic Disorders to M Okada; from JSPS
(17H06299) to Y Suzuki, from JST PRESTO (JPMJPR1507) and Japan AMED
(17ek0109187h0002) to T Yamada; and from JSPS (15H01522, 16H04901,
17H05654, and 18H04805) and JST PRESTO (JPMJPR1537) to S Fukuda.

Author Contributions
A Imamoto: conceptualization, data curation, formal analysis, supervision, investigation, and writing—original draft, review, and
editing.
S Ki: investigation.
L Li: investigation.
K Iwamoto: data curation and formal analysis.
V Maruthamuthu: investigation and methodology.
J Devany: software, investigation, and methodology.
O Lu: investigation.
T Kanazawa: investigation.
S Zhang: investigation.
T Yamada: data curation, software, formal analysis, and visualization.
A Hirayama: investigation.
S Fukuda: investigation and methodology.
Y Suzuki: investigation and methodology.
M Okada: conceptualization, supervision, funding acquisition, and
writing—review and editing.
Conﬂict of Interest Statement
The authors declare that they have no conﬂict of interest.

References
Alfano D, Altomonte A, Cortes C, Bilio M, Kelly RG, Baldini A (2019) Tbx1
regulates extracellular matrix-cell interactions in the second heart
ﬁeld. Hum Mol Genet 28: 2295–2308. doi:10.1093/hmg/ddz058
Asghari MH, Jalali B (2015) Edge detection in digital images using dispersive
phase stretch transform. Int J Biomed Imaging 2015: 1–6. doi:10.1155/
2015/687819
Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ (2009) An
integrative genomics approach identiﬁes Hypoxia Inducible Factor-1
(HIF-1)-target genes that form the core response to hypoxia. Nucleic
Acids Res 37: 4587–4602. doi:10.1093/nar/gkp425
Birge RB, Kalodimos C, Inagaki F, Tanaka S (2009) Crk and CrkL adaptor
proteins: Networks for physiological and pathological signaling. Cell
Commun Signal 7: 13. doi:10.1186/1478-811x-7-13

Supplementary Information

Bossi G, Gertosio C, Meazza C, Farello G, Bozzola M (2016) Failure to thrive as
presentation in a patient with 22q11.2 microdeletion. Ital J Pediatr 42:
14. doi:10.1186/s13052-016-0224-0

Supplementary Information is available at https://doi.org/10.26508/lsa.
201900635.

Bruno DL, Anderlid BM, Lindstrand A, van Ravenswaaij-Arts C,
Ganesamoorthy D, Lundin J, Martin CL, Douglas J, Nowak C, Adam MP,
et al (2010) Further molecular and clinical delineation of co-locating

The CRK family controls glucose metabolism and cell size

Imamoto et al.

https://doi.org/10.26508/lsa.201900635

vol 3 | no 2 | e201900635

16 of 18

17p13.3 microdeletions and microduplications that show distinctive
phenotypes. J Med Genet 47: 299–311. doi:10.1136/jmg.2009.069906
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig
M, Vandenhoeck A, Harpal K, Eberhardt C, et al (1996) Abnormal blood
vessel development and lethality in embryos lacking a single VEGF
allele. Nature 380: 435–439. doi:10.1038/380435a0
Carmeliet P, Dor Y, Herber JM, Fukumura D, Brusselmans K, Dewerchin M,
Neeman M, Bono F, Abramovitch R, Maxwell P, et al (1998) Role of HIF1α in hypoxia-mediated apoptosis, cell proliferation and tumour
angiogenesis. Nature 394: 485–490. doi:10.1038/28867
Chauvin C, Koka V, Nouschi A, Mieulet V, Hoareau-Aveilla C, Dreazen A,
Cagnard N, Carpentier W, Kiss T, Meyuhas O, et al (2014) Ribosomal
protein S6 kinase activity controls the ribosome biogenesis
transcriptional program. Oncogene 33: 474–483. doi:10.1038/
onc.2012.606
Cirillo E, Giardino G, Gallo V, Galasso G, Romano R, D’Assante R, Scalia G, Del
Vecchio L, Nitsch L, Genesio R, et al (2017) DiGeorge-like syndrome in a
child with a 3p12.3 deletion involving MIR4273 gene born to a mother
with gestational diabetes mellitus. Am J Med Genet A 173: 1913–1918.
doi:10.1002/ajmg.a.38242
Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF (2001) Membrane
blebbing during apoptosis results from caspase-mediated activation
of ROCK I. Nat Cell Biol 3: 339–345. doi:10.1038/35070009
Diederick (2019) Savitzky-Golay Smooth/Differentiation Filters and Filter
Application. MATLAB Central File Exchange, The MathWorks, Inc.
Available at: https://www.mathworks.com/matlabcentral/
ﬁleexchange/30299-savitzky-golay-smooth-differentiation-ﬁltersand-ﬁlter-application.
Digilio MC, Marino B, Formigari R, Giannotti A (1995) Maternal diabetes
causing DiGeorge anomaly and renal agenesis. Am J Med Genet 55:
513–514. doi:10.1002/ajmg.1320550427
Doe MR, Ascano JM, Kaur M, Cole MD (2012) Myc posttranscriptionally induces
HIF1 protein and target gene expression in normal and cancer cells.
Cancer Res 72: 949–957. doi:10.1158/0008-5472.can-11-2371
Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E,
Ma Q, Gorski R, Cleaver S, et al (2010) Activation of a metabolic gene
regulatory network downstream of mTOR complex 1. Mol Cell 39:
171–183. doi:10.1016/j.molcel.2010.06.022
Fackler OT, Grosse R (2008) Cell motility through plasma membrane
blebbing. J Cell Biol 181: 879–884. doi:10.1083/jcb.200802081
Feller SM (2001) CrK family adaptors-signalling complex formation and
biological roles. Oncogene 20: 6348–6371. doi:10.1038/sj.onc.1204779
Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell-Braxton L,
Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced
by targeted inactivation of the VEGF gene. Nature 380: 439–442.
doi:10.1038/380439a0
Fingar DC, Salama S, Tsou C, Harlow E, Blenis J (2002) Mammalian cell size is
controlled by mTOR and its downstream targets S6K1 and 4EBP1/
eIF4E. Genes Dev 16: 1472–1487. doi:10.1101/gad.995802

Fulcoli FG, Franzese M, Liu X, Zhang Z, Angelini C, Baldini A (2016) Rebalancing
gene haploinsufﬁciency in vivo by targeting chromatin. Nat Commun
7: 11688. doi:10.1038/ncomms11688
Ginzberg MB, Kafri R, Kirschner M (2015) Cell biology. On being the right (cell)
size. Science 348: 1245075. doi:10.1126/science.1245075
Gu L, Yi Z, Zhang Y, Ma Z, Zhu Y, Gao J (2017) Low dose of 2-deoxy-D-glucose
kills acute lymphoblastic leukemia cells and reverses glucocorticoid
resistance via N-linked glycosylation inhibition under normoxia.
Oncotarget 8: 30978–30991. doi:10.18632/oncotarget.16046
Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A (2001) Mice lacking the
homologue of the human 22q11.2 gene CRKL phenocopy
neurocristopathies of DiGeorge syndrome. Nat Genet 27: 293–298.
doi:10.1038/85855
Guris DL, Duester G, Papaioannou VE, Imamoto A (2006) Dose-dependent
interaction of Tbx1 and Crkl and locally aberrant RA signaling in a
model of del22q11 syndrome. Dev Cell 10: 81–92. doi:10.1016/
j.devcel.2005.12.002
Haller M, Mo Q, Imamoto A, Lamb DJ (2017) Murine model indicates 22q11.2
signaling adaptor CRKL is a dosage-sensitive regulator of
genitourinary development. Proc Natl Acad Sci U S A 114: 4981–4986.
doi:10.1073/pnas.1619523114
Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M,
Gearhart JD, Lawler AM, Yu AY, et al (1998) Cellular and developmental
control of O2 homeostasis by hypoxia- inducible factor 1α. Genes Dev
12: 149–162. doi:10.1101/gad.12.2.149
Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2:
Accurate alignment of transcriptomes in the presence of insertions,
deletions and gene fusions. Genome Biol 14: R36. doi:10.1186/gb-201314-4-r36
Konietschke F, Placzek M, Schaarschmidt F, Hothorn LA (2015) nparcomp: An R
software package for nonparametric multiple comparisons and
simultaneous conﬁdence intervals. J Stat Softw 64: 1–17. doi:10.18637/
jss.v064.i09
Lakshmikanthan S, Zheng X, Nishijima Y, Sobczak M, Szabo A, Vasquez-Vivar J,
Zhang DX, Chrzanowska-Wodnicka M (2015) Rap1 promotes
endothelial mechanosensing complex formation, NO release and
normal endothelial function. EMBO Rep 16: 628–637. doi:10.15252/
embr.201439846
Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memoryefﬁcient alignment of short DNA sequences to the human genome.
Genome Biol 10: R25. doi:10.1186/gb-2009-10-3-r25
Li L, Okura M, Imamoto A (2002) Focal adhesions require catalytic activity of
Src family kinases to mediate integrin-matrix adhesion. Mol Cell Biol
22: 1203–1217. doi:10.1128/mcb.22.4.1203-1217.2002
Liao Y, Smyth GK, Shi W (2014) FeatureCounts: An efﬁcient general purpose
program for assigning sequence reads to genomic features.
Bioinformatics 30: 923–930. doi:10.1093/bioinformatics/btt656
Lloyd AC (2013) The regulation of cell size. Cell 154: 1194–1205. doi:10.1016/
j.cell.2013.08.053

Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996)
Activation of vascular endothelial growth factor gene transcription by
hypoxia-inducible factor 1. Mol Cell Biol 16: 4604–4613. doi:10.1128/
mcb.16.9.4604

Lopez-Rivera E, Liu YP, Verbitsky M, Anderson BR, Capone VP, Otto EA, Yan Z,
Mitrotti A, Martino J, Steers NJ, et al (2017) Genetic drivers of kidney
defects in the DiGeorge syndrome. N Engl J Med 376: 742–754.
doi:10.1056/nejmoa1609009

Freeman SA, Christian S, Austin P, Iu I, Graves ML, Huang L, Tang S, Coombs D,
Gold MR, Roskelley CD (2017) Applied stretch initiates directional
invasion through the action of Rap1 GTPase as a tension sensor. J Cell
Sci 130: 152–163. doi:10.1242/jcs.180612

Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol 15: 550.
doi:10.1186/s13059-014-0550-8
Manning BD, Toker A (2017) AKT/PKB signaling: Navigating the network. Cell
169: 381–405. doi:10.1016/j.cell.2017.04.001

Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL (2002) Insulin-like
growth factor 1 induces hypoxia-inducible factor 1-mediated vascular
endothelial growth factor expression, which is dependent on MAP
kinase and phosphatidylinositol 3-kinase signaling in colon cancer
cells. J Biol Chem 277: 38205–38211. doi:10.1074/jbc.m203781200

McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman
JAS, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE, et al (2015)
22q11.2 deletion syndrome. Nat Rev Dis Primers 1: 15071. doi:10.1038/
nrdp.2015.71

The CRK family controls glucose metabolism and cell size

https://doi.org/10.26508/lsa.201900635

Imamoto et al.

vol 3 | no 2 | e201900635

17 of 18

Mjaavatten A (2019) Curvature of a 2D or 3D Curve. MATLAB Central File
Exchange, The MathWorks, Inc. Available at https://
www.mathworks.com/matlabcentral/ﬁleexchange/69452-curvatureof-a-2d-or-3d-curve.
Novak RW, Robinson HB (1994) Coincident DiGeorge anomaly and renal
agenesis and its relation to maternal diabetes. Am J Med Genet 50:
311–312. doi:10.1002/ajmg.1320500402
Ohba Y, Ikuta K, Ogura A, Matsuda J, Mochizuki N, Nagashima K, Kurokawa K,
Mayer BJ, Maki K, Miyazaki JI, et al (2001) Requirement for C3Gdependent Rap1 activation for cell adhesion and embryogenesis.
EMBO J 20: 3333–3341. doi:10.1093/emboj/20.13.3333
Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van
Dorpe J, Hellings P, Gorselink M, Heymans S, et al (2001) Deletion of the
hypoxia-response element in the vascular endothelial growth factor
promoter causes motor neuron degeneration. Nat Genet 28: 131–138.
doi:10.1038/88842
Park T, Boyd K, Curran T (2006) Cardiovascular and craniofacial defects in Crknull mice. Mol Cell Biol 26: 6272–6282. doi:10.1128/mcb.00472-06
Piecewicz SM, Pandey A, Roy B, Hua Xiang S, Zetter BR, Sengupta S (2012)
Insulin-like growth factors promote vasculogenesis in embryonic
stem cells. PLoS One 7: e32191. doi:10.1371/journal.pone.0032191

Simon MC, Keith B (2008) The role of oxygen availability in embryonic
development and stem cell function. Nat Rev Mol Cell Biol 9: 285–296.
doi:10.1038/nrm2354
Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, Von
Der Ohe M, Swillen A, Maes C, et al (2003) VEGF: A modiﬁer of the
del22q11 (DiGeorge) syndrome? Nat Med 9: 173–182. doi:10.1038/nm819
Stasevich TJ, Hayashi-Takanaka Y, Sato Y, Maehara K, Ohkawa Y, SakataSogawa K, Tokunaga M, Nagase T, Nozaki N, McNally JG, et al (2014)
Regulation of RNA polymerase II activation by histone acetylation in
single living cells. Nature 516: 272–275. doi:10.1038/nature13714
Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inﬂammasomes in health
and disease. Nature 481: 278–286. doi:10.1038/nature10759
Taliana N, Said E, Grech V (2017) DiGeorge phenotype in the absence of 22q11
deletion: A case report. Images Paediatr Cardiol 19: 8–9.
Tallquist MD, Soriano P (2000) Epiblast-restricted cre expression in MORE
mice: A tool to distinguish embryonic vs. extra-embryonic gene
function. Genesis 26: 113–115. doi:10.1002/(sici)1526-968x(200002)26:
2<113::aid-gene3>3.0.co;2-2
Uchiyama T, Irie M, Mori H, Kurokawa K, Yamada T (2015) FuncTree: Functional
analysis and visualization for large-scale omics data. PLoS One 10:
e0126967. doi:10.1371/journal.pone.0126967

Racedo SE, McDonald-Mcginn DM, Chung JH, Goldmuntz E, Zackai E, Emanuel
BS, Zhou B, Funke B, Morrow BE (2015) Mouse and human CRKL is
dosage sensitive for cardiac outﬂow tract formation. Am J Hum Genet
96: 235–244. doi:10.1016/j.ajhg.2014.12.025

Uetaki M, Tabata S, Nakasuka F, Soga T, Tomita M (2015) Metabolomic
alterations in human cancer cells by vitamin C-induced oxidative
stress. Sci Rep 5: 13896. doi:10.1038/srep13896

Ramı́rez F, Ryan DP, Grüning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S,
Dündar F, Manke T (2016) deepTools2: A next generation web server for
deep-sequencing data analysis. Nucleic Acids Res 44: W160–W165.
doi:10.1093/nar/gkw257

Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L,
Newman J, Reczek EE, Weissleder R, Jacks T (2007) Restoration of p53
function leads to tumour regression in vivo. Nature 445: 661–665.
doi:10.1038/nature05541

Roycroft A, Mayor R (2016) Molecular basis of contact inhibition of
locomotion. Cell Mol Life Sci 73: 1119–1130. doi:10.1007/s00018-0152090-0

Voss AK, Gruss P, Thomas T (2003) The guanine nucleotide exchange factor
C3G is necessary for the formation of focal adhesions and vascular
maturation. Development 130: 355–367. doi:10.1242/dev.00217

Roycroft A, Szabó A, Bahm I, Daly L, Charras G, Parsons M, Mayor R (2018)
Redistribution of adhesive forces through Src/FAK drives contact
inhibition of locomotion in neural crest. Dev Cell 45: 565–579.e3.
doi:10.1016/j.devcel.2018.05.003

Watanabe T, Tsuda M, Makino Y, Konstantinou T, Nishihara H, Majima T,
Minami A, Feller SM, Tanaka S (2009) Crk adaptor protein-induced
phosphorylation of Gab1 on tyrosine 307 via Src is important for
organization of focal adhesions and enhanced cell migration. Cell Res
19: 638–650. doi:10.1038/cr.2009.40

Ryan HE, Lo J, Johnson RS (1998) HIF-1alpha is required for solid tumor
formation and embryonic vascularization. EMBO J 17: 3005–3015.
doi:10.1093/emboj/17.11.3005
Saga Y, Miyagawa-Tomita S, Takagi A, Kitajima S, Miyazaki J, Inoue T (1999)
MesP1 is expressed in the heart precursor cells and required for the
formation of a single heart tube. Development 126: 3437–3447.
Sawada Y, Tamada M, Dubin-Thaler BJ, Cherniavskaya O, Sakai R, Tanaka S,
Sheetz MP (2006) Force sensing by mechanical extension of the Src
family kinase substrate p130Cas. Cell 127: 1015–1026. doi:10.1016/
j.cell.2006.09.044
Schmieder R, Edwards R (2011) Quality control and preprocessing of
metagenomic datasets. Bioinformatics 27: 863–864. doi:10.1093/
bioinformatics/btr026
Semenza GL (2010) Deﬁning the role of hypoxia-inducible factor 1 in cancer
biology and therapeutics. Oncogene 29: 625–634. doi:10.1038/
onc.2009.441
Semenza GL (2017) A compendium of proteins that interact with HIF-1α. Exp
Cell Res 356: 128–135. doi:10.1016/j.yexcr.2017.03.041
Shigeno-Nakazawa Y, Kasai T, Ki S, Kostyanovskaya E, Pawlak J, Yamagishi J,
Okimoto N, Taiji M, Okada M, Westbrook J, et al (2016) A pre-metazoan
origin of the CRK gene family and co-opted signaling network. Sci Rep
6: 34349. doi:10.1038/srep34349
Shin NY, Dise RS, Schneider-Mergener J, Ritchie MD, Kilkenny DM, Hanks SK
(2004) Subsets of the major tyrosine phosphorylation sites in Crkassociated substrate (CAS) are sufﬁcient to promote cell migration. J
Biol Chem 279: 38331–38337. doi:10.1074/jbc.m404675200

The CRK family controls glucose metabolism and cell size

Imamoto et al.

Wen H, Miao EA, Ting JP (2013) Mechanisms of NOD-like receptor-associated
inﬂammasome activation. Immunity 39: 432–441. doi:10.1016/
j.immuni.2013.08.037
Yu G, Wang LG, Han Y, He QY (2012) clusterProﬁler: An R package for
comparing biological themes among gene clusters. OMICS 16: 284–287.
doi:10.1089/omi.2011.0118
Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003) Cobalt inhibits the
interaction between hypoxia-inducible factor-alpha and von HippelLindau protein by direct binding to hypoxia-inducible factor-alpha. J
Biol Chem 278: 15911–15916. doi:10.1074/jbc.m300463200
Zhang Z, Huynh T, Baldini A (2006) Mesodermal expression of Tbx1 is
necessary and sufﬁcient for pharyngeal arch and cardiac outﬂow
tract development. Development 133: 3587–3595. doi:10.1242/
dev.02539
Zhao Y, Diacou A, Johnston HR, Musfee FI, McDonald-McGinn DM, McGinn D,
Crowley TB, Repetto GM, Swillen A, Breckpot J, et al (2020) Complete
sequence of the 22q11.2 allele in 1,053 subjects with 22q11.2 deletion
syndrome reveals modiﬁers of conotruncal heart defects. Am J Hum
Genet 106: 26–40. doi:10.1016/j.ajhg.2019.11.010

License: This article is available under a Creative
Commons License (Attribution 4.0 International, as
described at https://creativecommons.org/
licenses/by/4.0/).

https://doi.org/10.26508/lsa.201900635

vol 3 | no 2 | e201900635

18 of 18

